The memo lands on a Friday afternoon, always a Friday. “As part of our ongoing commitment to AI-first transformation,” it begins, and everyone in the Slack channel knows what comes next. Another round of layoffs. Another earnings call where the CEO will explain how artificial intelligence is making the company leaner, faster, more competitive. Another quarter where the stock ticks up while the parking lot empties out.
This is the Ozempic effect in corporate America. Just as the weight-loss drug promises a shortcut past the hard work of diet and exercise, AI has become the narrative shortcut past the hard work of actual innovation. The pitch is irresistible: tell Wall Street you’re replacing expensive humans with cheap algorithms, watch your stock price rise, and deal with the operational fallout later. If there is a fallout. If anyone is still around to notice.
The numbers are damning. Our analysis of 47 major tech companies that announced “AI-driven restructuring” between 2024 and early 2026 reveals a consistent pattern. The layoffs come first, fast and deep, typically cutting 15-30% of the workforce. The AI deployment comes later, if it comes at all. In the interim, surviving employees absorb the workload of their departed colleagues, burnout metrics spike, and product quality quietly degrades. But the quarterly numbers look fantastic. Revenue per employee soars. Operating margins expand. Analysts upgrade their ratings. The Ozempic is working.
What the market celebrates as efficiency, insiders describe as controlled demolition. “We fired the people who knew how things actually worked,” one engineering director at a major cloud provider told us, requesting anonymity. “Then we bought an enterprise AI license and told the board it was a lateral move. It wasn’t. We lost five years of institutional knowledge in a single afternoon.” The uncomfortable truth is that AI, in its current form, is exceptionally good at certain narrow tasks and remarkably bad at the kind of cross-functional judgment that experienced humans provide. But that nuance doesn’t fit in an earnings call. What fits is a story about the future, told in the language of inevitability, backed by the only metric that matters: the stock price went up.